| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.874 | 0.002 | 0.874 | HIV-1 reverse transcriptase inhibitor | 0.736 0.003 CID_154699973 | ||
| 0.603 | 0.004 | 0.603 | DNA directed RNA polymerase inhibitor | 0.389 0.005 CID_154699973 | ||
| 0.45 | 0.014 | 0.45 | RNA-directed DNA polymerase inhibitor | 0.419 0.016 CID_154699973 | ||
| 0.343 | 0.007 | 0.343 | Glutamate receptor antagonist | |||
| 0.351 | 0.029 | 0.351 | Anticonvulsant | |||
| 0.295 | 0.007 | 0.295 | Androgen antagonist | |||
| 0.326 | 0.041 | 0.346 | Hypolipemic | 0.346 0.036 CID_154699973 | CID_154699973 | |
| 0.275 | 0.004 | 0.275 | Progesterone antagonist | |||
| 0.222 | 0.005 | 0.222 | NMDA 2B receptor antagonist | |||
| 0.231 | 0.019 | 0.33 | ATPase inhibitor | 0.33 0.005 CID_154699973 | CID_154699973 | |
| 0.228 | 0.041 | 0.228 | Lipocortins synthesis antagonist | 0.161 0.091 CID_154699973 | ||
| 0.171 | 0.005 | 0.171 | Mineralocorticoid receptor antagonist | 0.058 0.021 CID_154699973 | ||
| 0.282 | 0.129 | 0.282 | Antiobesity | |||
| 0.296 | 0.145 | 0.296 | Analgesic | |||
| 0.297 | 0.166 | 0.602 | Cyclophilin D inhibitor | 0.602 0.027 CID_154699973 | CID_154699973 | |
| 0.138 | 0.03 | 0.138 | Estrogen antagonist | |||
| 0.117 | 0.017 | 0.117 | Potassium channel large-conductance Ca-activated activator | 0.075 0.039 CID_154699973 | ||
| 0.124 | 0.028 | 0.124 | Estrogen receptor beta antagonist | |||
| 0.092 | 0.005 | 0.092 | Glucocorticoid antagonist | 0.028 0.025 CID_154699973 | ||
| 0.094 | 0.011 | 0.094 | Glutamate (mGluR5) antagonist | |||
| 0.071 | 0.004 | 0.071 | Progesterone agonist | 0.027 0.008 CID_154699973 | ||
| 0.095 | 0.03 | 0.095 | Estrogen receptor alpha antagonist | |||
| 0.089 | 0.031 | 0.089 | Glutamate (mGluR group I) antagonist | |||
| 0.091 | 0.041 | 0.091 | Glutamate (mGluR) antagonist | |||
| 0.081 | 0.043 | 0.081 | NMDA 2 receptor antagonist | |||
| 0.05 | 0.03 | 0.05 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.039 | 0.035 | 0.039 | Dopamine D2 agonist | |||
| 0.211 | 0.217 | 0.597 | Antibacterial | 0.597 0.02 CID_154699973 | CID_154699973 | |
| 0.024 | 0.03 | 0.033 | Squalene synthetase inhibitor | 0.033 0.022 CID_154699973 | CID_154699973 | |
| 0.052 | 0.06 | 0.062 | Lipocortins synthesis agonist | 0.062 0.032 CID_154699973 | CID_154699973 | |
| 0.027 | 0.095 | 0.113 | Protein 50S ribosomal subunit inhibitor | 0.113 0.01 CID_154699973 | CID_154699973 | |
| 0.012 | 0.083 | 0.03 | Protein 30S ribosomal subunit inhibitor | 0.03 0.013 CID_154699973 | CID_154699973 | |
| 0.013 | 0.09 | 0.029 | Sodium/glucose cotransporter inhibitor | 0.029 0.012 CID_154699973 | CID_154699973 | |
| 0.033 | 0.116 | 0.133 | Antineoplastic antibiotic | 0.133 0.035 CID_154699973 | CID_154699973 | |
| 0.07 | 0.175 | 0.175 | Lipid peroxidase inhibitor | 0.175 0.053 CID_154699973 | CID_154699973 | |
| 0.079 | 0.2 | 0.122 | Diuretic | 0.122 0.102 CID_154699973 | CID_154699973 | |
| 0.041 | 0.168 | 0.113 | Topoisomerase I inhibitor | 0.113 0.06 CID_154699973 | CID_154699973 | |
| 0.02 | 0.147 | 0.056 | Antibiotic Aminoglycoside-like | 0.056 0.01 CID_154699973 | CID_154699973 | |
| 0.118 | 0.281 | 0.221 | DNA synthesis inhibitor | 0.221 0.093 CID_154699973 | CID_154699973 | |
| 0.044 | 0.209 | 0.107 | UDP-glucose 4-epimerase inhibitor | 0.107 0.054 CID_154699973 | CID_154699973 | |
| 0.072 | 0.272 | 0.223 | Nitric oxide antagonist | 0.223 0.06 CID_154699973 | CID_154699973 | |
| 0.031 | 0.249 | 0.053 | Adenine nucleotide translocase inhibitor | 0.053 0.046 CID_154699973 | CID_154699973 | |
| 0.105 | 0.39 | 0.318 | Peptidyltransferase inhibitor | 0.318 0.019 CID_154699973 | CID_154699973 | |
| 0.089 | 0.409 | 0.128 | CC chemokine 6 receptor antagonist | 0.128 0.077 CID_154699973 | CID_154699973 | |
| 0.018 | 0.347 | 0.049 | Glucose-6-phosphate translocase inhibitor | 0.049 0.042 CID_154699973 | CID_154699973 | |
| 0.051 | 0.405 | 0.154 | Insulin secretagoues | 0.154 0.07 CID_154699973 | CID_154699973 | |
| 0.023 | 0.389 | 0.082 | ATPase (Vacuolar H+) inhibitor | 0.082 0.073 CID_154699973 | CID_154699973 | |
| 0.067 | 0.449 | 0.192 | Cholesterol antagonist | 0.192 0.172 CID_154699973 | CID_154699973 | |
| 0.037 | 0.421 | 0.093 | Transcription factor NF kappa B stimulant | 0.093 0.047 CID_154699973 | CID_154699973 | |
| 0.066 | 0.451 | 0.432 | Antithrombotic | 0.432 0.042 CID_154699973 | CID_154699973 | |
| 0.041 | 0.464 | 0.3 | Antioxidant | 0.3 0.061 CID_154699973 | CID_154699973 | |
| 0.03 | 0.455 | 0.104 | Toll-Like receptor 4 antagonist | 0.104 0.063 CID_154699973 | CID_154699973 | |
| 0.03 | 0.493 | 0.257 | Free radical scavenger | 0.257 0.066 CID_154699973 | CID_154699973 | |
| 0.044 | 0.517 | 0.127 | NOS3 expression enhancer | 0.127 0.103 CID_154699973 | CID_154699973 | |
| 0.023 | 0.506 | 0.123 | Anticoagulant | 0.123 0.108 CID_154699973 | CID_154699973 | |
| 0.085 | 0.571 | 0.37 | Antiinflammatory | 0.37 0.158 CID_154699973 | CID_154699973 | |
| 0.033 | 0.62 | 0.272 | Immunosuppressant | 0.272 0.133 CID_154699973 | CID_154699973 | |
| 0.033 | 0.647 | 0.233 | Hepatoprotectant | 0.233 0.049 CID_154699973 | CID_154699973 | |
| 0.067 | 0.687 | 0.309 | Interleukin 2 agonist | 0.309 0.067 CID_154699973 | CID_154699973 | |
| 0.014 | 0.692 | 0.391 | Angiogenesis stimulant | 0.391 0.023 CID_154699973 | CID_154699973 | |
| 0.02 | 0.707 | 0.177 | Platelet adhesion inhibitor | 0.177 0.084 CID_154699973 | CID_154699973 | |
| 0.01 | 0.705 | 0.165 | Platelet antagonist | 0.165 0.13 CID_154699973 | CID_154699973 | |
| 0.004 | 0.734 | 0.182 | Selectin antagonist | 0.182 0.013 CID_154699973 | CID_154699973 | |
| 0.019 | 0.803 | 0.285 | Hypoglycemic | 0.285 0.058 CID_154699973 | CID_154699973 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |